Dhanvantri Jeevan Rekha Ltd

Dhanvantri Jeevan Rekha Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Sell to Hold as of 1 July 2026. This change reflects a combination of improved technical indicators, a more attractive valuation profile, steady financial trends, and a reassessment of the company’s overall quality metrics. The upgrade comes amid a strong recent price performance and positive quarterly results, signalling a cautious but optimistic outlook for investors.

Dhanvantri Jeevan Rekha Ltd, a micro-cap player in the healthcare services sector, has seen a notable shift in its valuation parameters, moving from a very attractive to an attractive rating. This change, coupled with its recent price performance and peer comparisons, offers investors a nuanced perspective on its price attractiveness and potential investment merit.

Dhanvantri Jeevan Rekha Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating downgraded from Sell to Strong Sell as of 12 May 2026. This revision follows a deterioration in technical indicators, coupled with weak financial trends and valuation concerns, signalling heightened risk for investors despite some recent positive quarterly results.

Dhanvantri Jeevan Rekha Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 30 March 2026. This change is primarily driven by an improvement in technical indicators, despite ongoing concerns over the company’s fundamental financial health and valuation metrics. The stock’s recent market performance and quarterly results provide a mixed picture, prompting a nuanced reassessment of its investment appeal.

Dhanvantri Jeevan Rekha Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 19 Mar 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality assessments, signalling a cautious but positive shift in the company’s outlook despite lingering fundamental challenges.

Dhanvantri Jeevan Rekha Ltd, a player in the Healthcare Services sector, has seen its investment rating downgraded from Sell to Strong Sell as of 10 March 2026. This revision reflects a combination of deteriorating technical indicators, weak long-term fundamentals, and valuation concerns despite some recent positive quarterly financial results.

Dhanvantri Jeevan Rekha Ltd, a player in the Healthcare Services sector, has seen its investment rating downgraded from Sell to Strong Sell as of 5 March 2026. This shift reflects a complex interplay of deteriorating technical indicators, weak long-term financial fundamentals, and valuation concerns despite some recent positive quarterly results. The company’s Mojo Score now stands at 29.0, signalling heightened caution for investors amid volatile market conditions and subdued operational performance.

Dhanvantri Jeevan Rekha Ltd, a player in the healthcare services sector, has seen its investment rating downgraded from Sell to Strong Sell as of 18 Feb 2026. Despite some positive quarterly financial results, the company’s overall quality, valuation, financial trend, and technical indicators present a complex picture that has led to a cautious stance among investors.

Dhanvantri Jeevan Rekha Ltd., a micro-cap healthcare services provider based in Meerut, reported a sharp operational turnaround in Q3 FY26, posting net profit of ₹0.17 crores—a dramatic recovery from the ₹0.14 crore loss recorded in Q2 FY26. However, with a market capitalisation of just ₹10.00 crores and elevated valuation metrics, the company's financial fragility remains a significant concern for investors despite the sequential improvement.

Dhanvantri Jeevan Rekha Ltd, a player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 4 February 2026. This change reflects a nuanced shift in the company’s technical outlook despite persistent fundamental challenges. The upgrade is driven primarily by improvements in technical indicators, while valuation and financial trends remain subdued, underscoring a cautious stance for investors.

Dhanvantri Jeevan Rekha Ltd, a player in the Healthcare Services sector, has seen its investment rating downgraded from Sell to Strong Sell as of 30 Jan 2026. Despite some mild technical improvements, the company’s weak financial trends and poor valuation metrics have weighed heavily on its overall assessment, prompting a reassessment of its investment appeal.

Dhanvantri Jeevan Rekha Ltd is rated Sell by MarketsMOJO, with this rating last updated on 03 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 December 2025, providing investors with the latest insights into its performance and outlook.

Dhanvantri Jeev., a microcap player in the Healthcare Services sector, has experienced a revision in its market evaluation reflecting recent shifts in its financial and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, signalling a more cautious stance from market analysts.